These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 5696878)

  • 1. The influence of age on the recovery of cardiac monoamine oxidase after irreversible inhibition.
    Horita A
    Biochem Pharmacol; 1968 Oct; 17(10):2091-6. PubMed ID: 5696878
    [No Abstract]   [Full Text] [Related]  

  • 2. Substrate-selective and tissue-selective inhibition of monoamine oxidase.
    Fuller RW; Roush BW
    Arch Int Pharmacodyn Ther; 1972 Aug; 198(2):270-6. PubMed ID: 5054735
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparison of the inhibitory effects of propargylamine and pargyline on brain and liver monoamine oxidase activity.
    Abeles RH; Tashjian AH
    Biochem Pharmacol; 1975 Jan; 24(2):307-8. PubMed ID: 1111545
    [No Abstract]   [Full Text] [Related]  

  • 4. Spontaneous peripheral leakage of pargyline on intracerebroventricular administration.
    Ali B; Parmar SS; Seth PK; Brumleve SJ
    Res Commun Chem Pathol Pharmacol; 1973 Nov; 6(3):1083-6. PubMed ID: 4760882
    [No Abstract]   [Full Text] [Related]  

  • 5. Turnover rates of monoamine oxidases: recovery of the irreversibly inhibited enzyme activity and the influence of isoproterenol.
    Planz G; Quiring K; Palm D
    Life Sci I; 1972 Feb; 11(3):147-60. PubMed ID: 4653196
    [No Abstract]   [Full Text] [Related]  

  • 6. Differential development, inhibition, and recovery of monoamine oxidase in various parts of the rat heart.
    Horita A
    Res Commun Chem Pathol Pharmacol; 1970 Nov; 1(6):713-20. PubMed ID: 5524271
    [No Abstract]   [Full Text] [Related]  

  • 7. MD 240928 and harmaline: opposite selectivity in antagonism of the inactivation of types A and B monoamine oxidase by pargyline in mice.
    Fuller RW; Wong CJ; Hemrick-Luecke SK
    Life Sci; 1986 Feb; 38(5):409-12. PubMed ID: 3945167
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rates of recovery of irreversibly inhibited monoamine oxidases: a measure of enzyme protein turnover.
    Planz G; Quiring K; Palm D
    Naunyn Schmiedebergs Arch Pharmacol; 1972; 273(1):27-42. PubMed ID: 4260803
    [No Abstract]   [Full Text] [Related]  

  • 9. Molecular turnover numbers of different forms of mitochondrial monoamine oxidase in rat.
    Egashira T; Ekstedt B; Kinemuchi H; Wiberg A; Oreland L
    Med Biol; 1976 Aug; 54(4):272-7. PubMed ID: 957813
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Synthesis of monoamine oxidase in subcellular structures in normal conditions and in alcoholism].
    Moskvitina TA
    Biomed Khim; 2006; 52(2):169-73. PubMed ID: 16805388
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monoamine oxidase inhibiting properties of SU-11,739 in the rat. Comparison with pargyline, tranylcypromine and iproniazid.
    Maître L
    J Pharmacol Exp Ther; 1967 Jul; 157(1):81-8. PubMed ID: 6029494
    [No Abstract]   [Full Text] [Related]  

  • 12. Different sensitivity of mitochondrial and cytosolic monoamine oxidases to in vivo but not in vitro inhibition by specific irreversible inhibitors.
    Moskvitina TA; Medvedev AE
    Med Sci Monit; 2001; 7(1):17-9. PubMed ID: 11208486
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The labeling in vivo of monoamine oxidase by 14 C-pargyline: a tool for studying the synthesis of the enzyme.
    Erwin VG; Deitrich RA
    Mol Pharmacol; 1971 Mar; 7(2):219-28. PubMed ID: 5125856
    [No Abstract]   [Full Text] [Related]  

  • 14. [Mechanism of action of adrenaline and some other biogenic amines on gamma-amylase activity of rat liver and heart muscle].
    Orlova VS; Siniukhin VN; Popova IA; Gorkin VZ; Rozenfel'd EL
    Biokhimiia; 1971; 36(3):555-61. PubMed ID: 5132486
    [No Abstract]   [Full Text] [Related]  

  • 15. Some considerations in the design of substrate and tissue-specific inhibitors of monoamine oxidase.
    Martin YC; Biel JH
    Adv Biochem Psychopharmacol; 1974; 12(0):37-48. PubMed ID: 4417042
    [No Abstract]   [Full Text] [Related]  

  • 16. Monoamine oxidase inhibition and recovery in the mouse brain at various ages after birth.
    Samsa JM; Baker PC; Hoff KM
    Biol Neonate; 1979; 35(5-6):249-54. PubMed ID: 476197
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monoamine oxidase-III. Further studies of inhibition by propargylamines.
    Williams CH; Lawson J
    Biochem Pharmacol; 1975 Oct; 24(20):1889-91. PubMed ID: 1191339
    [No Abstract]   [Full Text] [Related]  

  • 18. Inhibition by pargyline of cardiovascular amine oxidase activity.
    Fuentes JA; Neff NH
    Biochem Pharmacol; 1977 Nov; 26(22):2107-12. PubMed ID: 588291
    [No Abstract]   [Full Text] [Related]  

  • 19. Developmental aspects of rat heart monoamine oxidase.
    Edwards DJ; Koon Yan Pak ; Venetti MC
    Biochem Pharmacol; 1979 Aug; 28(15):2337-43. PubMed ID: 497016
    [No Abstract]   [Full Text] [Related]  

  • 20. The effect of ethanol consumption on the sensitivity of rat brain monoamine oxidases to the inhibition by pargyline in vivo and in vitro.
    Panova NG; Axenova LN; Medvedev AE
    Neurobiology (Bp); 2000; 8(3-4):225-30. PubMed ID: 11225512
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.